Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS) SHH

Currency In CNY

AD

Valuation

Market Cap6.28B
Enterprise Value6.26B
P/E Ratio26.31
PEG Ratio0.12
Price/Sales Ratio4.93
Price/Book Ratio1.4
Enterprise/Revenue4.97
Enterprise/EBITDA21.49

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.19
Operating Margin0.23
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.05

Income Statement

Revenue915.12M
Revenue/Share5.86
Gross Profit822.87M
EBITDA233.49M
Net Income165.97M
Diluted EPS1.04

Balance Sheet

Total Cash921.09M
Total Cash/Share5.89
Total Debt376.9M
Total Debt/Equity0.12
Current Ratio2.55
Book Value Per Share22.21

Price History

52-Week Change-46.48
52-Week High61.8
52-Week Low27.33
Moving Average 50 Days31.92
Moving Average 200 Days36.57

Statistics

Average Volume3.66M
Shares Outstanding159.01M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.35
Trailing Annual Dividend Yield1.23
Payout Ratio0.6
Last Split FactorN/A
Last Split DateN/A
AD